Cargando…
Impact of cibenzoline treatment on left ventricular remodelling and prognosis in hypertrophic obstructive cardiomyopathy
AIMS: This study aimed to elucidate the long‐term effect of cibenzoline therapy on cardiovascular complications and prognosis in patients with hypertrophic obstructive cardiomyopathy (HOCM). METHODS AND RESULTS: Eighty‐eight patients with HOCM were treated with cibenzoline (Group A), and 41 patients...
Autores principales: | Hamada, Mareomi, Shigematsu, Yuji, Ikeda, Shuntaro, Ohshima, Kiyotaka, Ogimoto, Akiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712831/ https://www.ncbi.nlm.nih.gov/pubmed/34713615 http://dx.doi.org/10.1002/ehf2.13672 |
Ejemplares similares
-
Predicting the clinical course in hypertrophic cardiomyopathy using thallium‐201 myocardial scintigraphy
por: Hamada, Mareomi, et al.
Publicado: (2021) -
Editorial: Cibenzoline for left ventricular outflow tract obstruction in tako-tsubo cardiomyopathy and hypertrophic cardiomyopathy
por: Anan, Ryuichiro
Publicado: (2015) -
Left Ventricular Thrombus in Hypertrophic Cardiomyopathy
por: Hamada, Mareomi
Publicado: (2018) -
Transmitral Doppler Flow Pattern in Left Atrial Myxoma
por: Hamada, Mareomi, et al.
Publicado: (2018) -
Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure
por: Ikeda, Shuntaro, et al.
Publicado: (2017)